Evidence map›Paper›PMID 40540509›Full record

ArticlePloS one2025

Implementation of early warning, alert and response: An experience from the Marburg virus disease outbreak response in Kagera, Tanzania, March to May 2023.

Atuganile Musyani, Emmanuel Mwakapasa, Marcelina Mponela, Lusungu Ngailo, Irene Rabiel, Mwanakombo Khama, Eninka Mmbaga, Calvin Sindato, Mololo Noah, Werema Solomon and 26 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Atuganile MusyaniAmref Health Africa Tanzania, Dar es Salaam, Tanzania.ORCID 0000-0003-2138-7139
Emmanuel MwakapasaMinistry of Health (MoH), Dodoma, Tanzania.
Marcelina MponelaTanzania Country Office of the U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Lusungu NgailoAmref Health Africa Tanzania, Dar es Salaam, Tanzania.
Irene RabielAmref Health Africa Tanzania, Dar es Salaam, Tanzania.
Mwanakombo KhamaAmref Health Africa Tanzania, Dar es Salaam, Tanzania.
Eninka MmbagaAmref Health Africa Tanzania, Dar es Salaam, Tanzania.
Calvin SindatoNational Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
Mololo NoahPrime Minister's Office (PMO), Dodoma, Tanzania.
Werema SolomonMinistry of Health (MoH), Dodoma, Tanzania.
George MremaMinistry of Health (MoH), Dodoma, Tanzania.
Danstan NgenziMinistry of Health (MoH), Dodoma, Tanzania.
George KaukiWorld Health Organization (WHO), Tanzania Country Office, Dar es Salaam, Tanzania.
Gerald ManassehPresident's Office, Regional Administration and Local Government (PO-RALG), Dodoma, Tanzania.
Michael MahandeManagement and Development for Health (MDH), Dodoma, Tanzania.
Emmanuel SarakikyaManagement and Development for Health (MDH), Dodoma, Tanzania.
Wilhellmuss MaukaManagement and Development for Health (MDH), Dodoma, Tanzania.
Lameck MachumiManagement and Development for Health (MDH), Dodoma, Tanzania.
Jonathan McharoNational Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
Mikidadi MtalikaTanzania Wildlife Research Institute (TAWIRI), Arusha, Tanzania.
Christer KanyankoreMinistry of Health (MoH), Dodoma, Tanzania.
Kokuhabwa MukurasiTanzania Country Office of the U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Medard BeyangaMinistry of Health (MoH), Dodoma, Tanzania.
Pius HorumpendeMinistry of Health (MoH), Dodoma, Tanzania.
Michael KiremejiMinistry of Health (MoH), Dodoma, Tanzania.ORCID 0009-0006-6503-1977
Erick KinyenjeMinistry of Health (MoH), Dodoma, Tanzania.
Emmanuel MnkeniMinistry of Health (MoH), Dodoma, Tanzania.
Missana YangoMinistry of Health (MoH), Dodoma, Tanzania.
Faith Melchiory KundyMinistry of Health (MoH), Dodoma, Tanzania.
Sibomana LeonardMinistry of Health (MoH), Dodoma, Tanzania.ORCID 0000-0003-4072-5711
Patrick MwanahapaMinistry of Health (MoH), Dodoma, Tanzania.
Rita MutayobaAmref Health Africa Tanzania, Dar es Salaam, Tanzania.
Mary MayigeNational Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
Wangeci GateiTanzania Country Office of the U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Vida MmbagaMinistry of Health (MoH), Dodoma, Tanzania.
Grace MagembeMinistry of Health (MoH), Dodoma, Tanzania.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionTanzania declared a Marburg Virus Disease (MVD) outbreak on March 21, 2023, reporting nine cases and six deaths (case fatality rate (CFR) 66.7%). Detection began when a Community Health Worker (CHW) reported unexplained illness via the electronic EBS (e-EBS) system, triggering a national outbreak response. This study documents the Early Warning, Alert and Response (EWAR) interventions carried out during the MVD outbreak response in the Kagera region to identify strengths and bottlenecks for strengthening future outbreak preparedness and response efforts.

methodWe documented EWAR interventions using retrospective surveillance document review. MVD outbreak detection and reporting timeliness were compared with Tanzania's EBS indicators and the 7-1-7 target. Surveillance interventions included additional staff deployment, equipment addition, and tool adoption. Community sensitization efforts utilized Swahili-translated informational cards to facilitate early detection and reporting of signals through multiple channels, including the 199-hotline number, EBS desk numbers and via e-EBS and verified using the standard case definition (SCD). Signals were compiled in Microsoft Excel, where descriptive analysis using frequencies to show trends was conducted. Suspected MVD cases were sent for laboratory confirmation.

findingsOn March 15, 2023, a CHW reported a signal in the e-EBS system within 24 hours. However, a community member and HCWs missed unusual signs of the MVD index case. Five additional members were deployed to support data management using the equipment provided, including three laptops, ten smartphones, and adapted tools. A total of 6,260 informational cards were distributed during community sensitization; 176 MVD signals were reported, where 48 (27.3%) met the SCD, and 37 were sent for laboratory confirmation, of which 2.7% tested positive for the virus. Most signals, 107 (60.8%), were reported in April. CONCLUSIONS AND RECOMMENDATIONS: The government should adopt the 7-1-7 target and strengthen community and health facility EBS through ongoing mentorship for EWAR.

Indexed as

Disease OutbreaksMarburg Virus DiseaseFemaleHumansMarburgvirusRetrospective StudiesTanzania

Identifiers

PMID40540509
PMCPMC12180656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.